Table 2 Factors associated with DFS and OS in the studied population.
Factor | No. of patients | No. of relapses | No. of deaths | Mean DFS (95% CI) | DFS (%) | DFS p-value | Mean OS (95% CI) | OS (%) | OS p-value | aOR for relapse (95% CI) | P-value |
|---|---|---|---|---|---|---|---|---|---|---|---|
Age | |||||||||||
< 62 | 6 | 0 | 0 | – | 100.0 | 0.084 | – | 100.0 | 0.246 | – | |
≥ 62 | 10 | 4 | 2 | – | 60.0 | – | 80.0 | – | |||
Gender | |||||||||||
Female | 11 | 4 | 2 | – | 63.6 | 0.116 | – | 81.8 | 0.300 | – | |
Male | 5 | 0 | 0 | – | 100.0 | – | 100.0 | – | |||
pT status | |||||||||||
T0 | 8 | 2 | 0 | 37.2 (28.8–45.7) | 75.0 | 0.973 | – | 100.0 | 0.173 | – | |
T + | 8 | 2 | 2 | 33.6 (23.5–43.7) | 75.0 | – | 75.0 | – | |||
pN status | |||||||||||
N0 | 15 | 4 | 2 | – | 73.3 | 0.550 | – | 86.7 | 0.699 | – | |
N + | 1 | 0 | 0 | – | 100.0 | – | 100.0 | – | |||
Brandwein scale | |||||||||||
Low risk | 1 | 1 | 0 | 33.0 (33.0–33.0) | 0.0 | 0.508 | – | 100.0 | 0.660 | – | |
Intermidiate risk | 4 | 1 | 0 | 27.8 (17.1–38.4) | 75.0 | – | 100.0 | – | |||
High risk | 10 | 2 | 2 | 36.9 (28.5–42.9) | 80.0 | – | 80.0 | – | |||
CD4+ CD69+ in sentinel node | |||||||||||
≤ 37.5 (low) | 7 | 3 | 2 | 19.7 (12.6–26.9) | 57.1 | 0.033 | – | 71.4 | 0.064 | Ref | 0.295 |
> 37.5 (high) | 9 | 1 | 0 | 42.6 (40.1–45.1) | 88.9 | – | 100.0 | 0.004 (0.00–119.70) | |||
CD8+ CDHLA-DR+ in sentinel node | |||||||||||
< 25.2 (low) | 8 | 0 | 0 | – | 100.0 | 0.045 | – | 100.0 | 0.141 | Ref | 0.248 |
≥ 25.2 (high) | 8 | 4 | 2 | – | 50.0 | – | 75.0 | 136.5 (0.033–569,208.6) | |||
